Home
Neoadjuvant Stereotactic Body Radiotherapy After Upfront Chemotherapy Improves Pathologic Outcomes Compared With Chemotherapy Alone for Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma Without Increasing Perioperative Toxicity

Neoadjuvant Stereotactic Body Radiotherapy After Upfront Chemotherapy Improves Pathologic Outcomes Compared With Chemotherapy Alone for Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma Without Increasing Perioperative Toxicity

Acest material este disponibil doar utilizatorilor înregistrați în platformă. Vă rugăm să vă logați sau să solicitați un cont de utilizator pentru a avea acces la conținutul științific.

Oana Isache

Asociația Română de Chirurgie Hepato-Bilio-Pancreatică și Transplant Hepatic

Despre
Noutăți
GDPR

Link-uri utile

Cursuri
Cum funcționează
Solicită cont

Contact

0722 904 715
IC Fundeni; Șos.Fundeni 258, București
contact@chirurgiehbp.ro

Neoadjuvant Stereotactic Body Radiotherapy After Upfront Chemotherapy Improves Pathologic Outcomes Compared With Chemotherapy Alone for Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma Without Increasing Perioperative Toxicity

Neoadjuvant Stereotactic Body Radiotherapy After Upfront Chemotherapy Improves Pathologic Outcomes Compared With Chemotherapy Alone for Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma Without Increasing Perioperative Toxicity

99mTc-GSA scintigraphy for assessing the functional volume ratio of the future liver remnant in the routine practice of liver resection

A locally advanced pancreatic body cancer presenting common bile duct invasion resected via distal pancreatectomy after gemcitabine plus nab-paclitaxel chemotherapy: A case report

Asociația Română de Chirurgie Hepato-Bilio-Pancreatică și Transplant Hepatic

Link-uri utile

Contact

Neoadjuvant Stereotactic Body Radiotherapy After Upfront Chemotherapy Improves Pathologic Outcomes Compared With Chemotherapy Alone for Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma Without Increasing Perioperative Toxicity

99mTc-GSA scintigraphy for assessing the functional volume ratio of the future liver remnant in the routine practice of liver resection

A locally advanced pancreatic body cancer presenting common bile duct invasion resected via distal pancreatectomy after gemcitabine plus nab-paclitaxel chemotherapy: A case report

Similare

Simpozion ARCHBPTH, IASGO la Congresul Național de Chirurgie din 14 iunie 2024

Simpozion ARCHBPTH, IASGO la Congresul Național de Chirurgie, 14 iunie 2024

Guidelines for Perioperative Care for Liver Transplantation: Enhanced Recovery After Surgery (ERAS) Recommendations

Asociația Română de Chirurgie Hepato-Bilio-Pancreatică și Transplant Hepatic​

Link-uri utile

Contact

Asociația Română de Chirurgie Hepato-Bilio-Pancreatică și Transplant Hepatic